Iron Triangle Partners LP In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Iron Triangle Partners LP reported 24 stock positions worth $954.0 million . Its top holding was Edwards Lifesciences (EW) at 7.0% of the portfolio, followed by Dexcom (DXCM, 6.9% ) and Glaukos (GKOS, 6.3% ). Compared with Q1 2024, it opened 9 new positions, sold out of 13, added to 10 and reduced 5. The biggest buy was a new position in Edwards Lifesciences (EW) and the biggest sale an exit from Icon (ICLR).
Location Cos Cob, CT
CIK 0001779763
Portfolio Value $954.0M (Q2 2024) Holdings 24 stocks · $954.0M Holdings quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2024 EW Edwards Lifesciences Corp. 727,180 $67.2M New DXCM Dexcom Inc. 582,199 $66.0M Add +23.4% GKOS Glaukos Corp. 508,156 $60.1M Add +18.3% ACHC Acadia Healthcare Co. Inc. 839,075 $56.7M Reduce -7.1% ISRG Intuitive Surgical Inc. 120,986 $53.8M Reduce -2.7% MCK McKesson Corp. 92,125 $53.8M Add +146.2% TEVA Teva Pharmaceutical-SP ADR 3,300,185 $53.6M Add +19.1% PODD Insulet Corp. 264,041 $53.3M New ABBV Abbvie Inc. 284,657 $48.8M Add +3.1% DHR Danaher Corp. 187,011 $46.7M New ELAN Elanco Animal Health Inc. 3,228,439 $46.6M Add +148.9% BMRN Biomarin Pharmaceutical Inc. 555,140 $45.7M New WST West Pharmaceutical Services 132,908 $43.8M Add +11.0% BKD Brookdale Senior Living Inc. 5,801,941 $39.6M Reduce -1.6% INSP Inspire Medical Systems Inc. 281,992 $37.7M New OSCR Oscar Health Inc. Class A 1,832,256 $29.0M Add +37.3% INSM Insmed Inc. 413,196 $27.7M New NBIX Neurocrine Biosciences Inc. 200,000 $27.5M Reduce -9.1% ARGX Argenx SE - ADR 61,704 $26.5M Add +37.1% TWST Twist Bioscience Corp. 526,455 $25.9M New SDGR Schrodinger Inc. 1,133,102 $21.9M Add +31.3% AGL Agilon Health Inc. 2,519,416 $16.5M New MASS 908 Devices Inc. 728,865 $3.8M Reduce -30.0% ALMS Alumis Inc. 125,000 $1.7M New
Options reported separately and not counted above: ACHC calls ($20.1M), ELAN calls ($9.5M).
Portfolio Sells Q1 2024 → Q2 2024 Portfolio Sells quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▲ ICLR Icon PLC Sold out 0.00% −5.24 EXAS Exact Sciences Corp. Sold out 0.00% −5.00 ALGN Align Technology Inc. Sold out 0.00% −4.82 ILMN Illumina Inc. Sold out 0.00% −4.70 BRKR Bruker Corp. Sold out 0.00% −4.53 APLS Apellis Pharmaceuticals Inc. Sold out 0.00% −3.35 FTRE Fortrea Holdings Inc. Sold out 0.00% −3.29 AVTR Avantor Inc. Sold out 0.00% −3.04 SWAV Shockwave Medical Inc. Sold out 0.00% −2.69 SNDX Syndax Pharmaceuticals Inc. Sold out 0.00% −2.40 XBI SS SPDR S&P Biotech ETF Sold out 0.00% −2.22 CYTK Cytokinetics Inc. Sold out 0.00% −2.18 ACHC Acadia Healthcare Co. Inc. Reduce -7.1% 5.94% −1.46 MASS 908 Devices Inc. Reduce -30.0% 0.39% −0.42 NYXH Nyxoah SA Sold out 0.00% −0.35 NBIX Neurocrine Biosciences Inc. Reduce -9.1% 2.89% −0.25 BKD Brookdale Senior Living Inc. Reduce -1.6% 4.15% +0.12 ISRG Intuitive Surgical Inc. Reduce -2.7% 5.64% +0.51
Portfolio Buys Q1 2024 → Q2 2024 Portfolio Buys quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▼ EW Edwards Lifesciences Corp. New 7.04% +7.04 PODD Insulet Corp. New 5.59% +5.59 DHR Danaher Corp. New 4.90% +4.90 BMRN Biomarin Pharmaceutical Inc. New 4.79% +4.79 INSP Inspire Medical Systems Inc. New 3.96% +3.96 MCK McKesson Corp. Add +146.2% 5.64% +3.56 INSM Insmed Inc. New 2.90% +2.90 TWST Twist Bioscience Corp. New 2.72% +2.72 ELAN Elanco Animal Health Inc. Add +148.9% 4.88% +2.70 GKOS Glaukos Corp. Add +18.3% 6.30% +2.11 AGL Agilon Health Inc. New 1.73% +1.73 TEVA Teva Pharmaceutical-SP ADR Add +19.1% 5.62% +1.58 OSCR Oscar Health Inc. Class A Add +37.3% 3.04% +0.98 ARGX Argenx SE - ADR Add +37.1% 2.78% +0.95 ALMS Alumis Inc. New 0.17% +0.17 DXCM Dexcom Inc. Add +23.4% 6.92% +0.15 ABBV Abbvie Inc. Add +3.1% 5.12% −0.08 SDGR Schrodinger Inc. Add +31.3% 2.30% −0.12 WST West Pharmaceutical Services Add +11.0% 4.59% −0.31
Options Activity Q1 2024 → Q2 2024 Security Type Change vs Q1 2024 Underlying Shares Value ▼ ACHC Acadia Healthcare Co. Inc. call New 298,200 $20.1M ELAN Elanco Animal Health Inc. call Add +8.2% 660,800 $9.5M
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q4 2025 27 $874.7M CRL, ISRG, RGEN, JAZZ, VCYT Q3 2025 25 $703.3M CVS, DXCM, ABBV, MDT, CRL Q2 2025 26 $631.9M CVS, CRL, ABBV, MMSI, ICLR Q1 2025 27 $634.4M DVA, CAH, ABBV, TEVA, BSX Q4 2024 22 $857.9M A, GMED, ABBV, UNH, TEVA Q3 2024 24 $711.2M MEDP, ELAN, ILMN, THC, ACHC Q2 2024 24 $954.0M EW, DXCM, GKOS, ACHC, ISRG Q1 2024 28 $966.4M ACHC, DXCM, ICLR, ABBV, ISRG